The average total monthly premium for Medicare Part D coverage is expected to fall to $55.50 in 2024, representing a 1.8% decrease from 2023 at $56.49, the Centers for Medicare and Medicaid Services (CMS) announced Monday.
“Stable premiums for Medicare prescription drug coverage in 2024 are supported by improvements to the Part D program in the Inflation Reduction Act (IRA), or the prescription drug law, that allow people with Medicare to benefit from reduced costs,” CMS said in a fact sheet.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Medicare Part D program is intended to help Medicare enrollees pay for brand-name and generic drugs. More than 51 million people are enrolled in Part D plans. The average total Part D premium is made up of the average basic premium (for the basic benefit offered by Part D plans) and the average supplemental premium. Many Part D plans offer a “richer benefit” than the basic Part D plan — such as coverage of some non-Part D drugs — and therefore charge a “supplemental premium.”
Although the 2024 average total monthly premium for Part D plans is expected to be lower than 2023, it will still be higher than in 2020 ($43.29), 2021 ($46.69) and 2022 ($51.66).
The projected average total monthly Part D premium is calculated “based on plan bids submitted to CMS,” a news release stated. The agency released it “to help individuals understand overall Part D premium trends before Medicare Open Enrollment when they can select from plan options for the upcoming benefit year.” The Medicare Open Enrollment period begins October 15.
There are a couple of reasons why the average Part D monthly premium is expected to decrease, according to CMS. One reason is that starting in 2024, the Inflation Reduction Act limits premium increases for Part D enrollees.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“Specifically, the law limits the growth in the base beneficiary premium (used to calculate the plan-specific basic premium) to a 6% annual increase. … By capping the base beneficiary premium, the [Inflation Reduction Act’s] premium stabilization provision has moderated the growth in the average basic premium, which, when taken with a lower average supplemental premium, results in a lower average total premium,” CMS said in the fact sheet.
Additionally, the Inflation Reduction Act will limit annual out-of-pocket costs, limit cost-sharing for covered insulin products and remove cost-sharing for recommended adult vaccines in 2024. Starting next year, Part D plans also have to apply price concessions from pharmacies “to lower the price the beneficiary pays at the point of sale,” according to CMS.
“These changes enhance the basic Part D benefit for 2024, resulting in better coverage available to all Part D beneficiaries while reducing premiums for supplemental Part D coverage,” CMS stated.
CMS will release the 2024 premium and cost-sharing information for Medicare Advantage and Part D plans in September.
Photo: designer491, Getty Images
